| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.2 | 1e-05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.002 |